161 related articles for article (PubMed ID: 37246457)
1. Effect of delayed hospitalization on 3-year clinical outcomes according to renal function in patients with non-ST-segment elevation myocardial infarction.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Park S; Kang DO; Park JY; Park SH; Jeong MH
Cardiol J; 2024; 31(2):271-284. PubMed ID: 37246457
[TBL] [Abstract][Full Text] [Related]
2. Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2022 Mar; 99(4):1022-1037. PubMed ID: 34962070
[TBL] [Abstract][Full Text] [Related]
3. Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
Atherosclerosis; 2022 Mar; 344():60-70. PubMed ID: 34924173
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Percutaneous Coronary Intervention During Non-ST-Segment-Elevation Myocardial Infarction in Elderly Patients With Chronic Kidney Disease.
Holzmann MJ; Siddiqui AJ
J Am Heart Assoc; 2020 Jun; 9(12):e015084. PubMed ID: 32519559
[TBL] [Abstract][Full Text] [Related]
5. Effects of delayed hospitalization on the 3-year clinical outcomes of patients with or without diabetes who had non-ST-segment-elevation myocardial infarction and underwent new-generation drug-eluting stent implantation.
Kim YH; Her AY; Rha SW; Choi CU; Choi BG; Kim JB; Kang DO; Park JY; Park SH; Jeong MH
Catheter Cardiovasc Interv; 2023 May; 101(6):1014-1027. PubMed ID: 36923997
[TBL] [Abstract][Full Text] [Related]
6. Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
Bagai A; Lu D; Lucas J; Goyal A; Herzog CA; Wang TY; Goodman SG; Roe MT
J Am Heart Assoc; 2018 Dec; 7(24):e010394. PubMed ID: 30514137
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention.
Stehli J; Martin C; Brennan A; Dinh DT; Lefkovits J; Zaman S
J Am Heart Assoc; 2019 May; 8(10):e012161. PubMed ID: 31092091
[TBL] [Abstract][Full Text] [Related]
8. Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.
Bhatia S; Arora S; Bhatia SM; Al-Hijji M; Reddy YNV; Patel P; Rihal CS; Gersh BJ; Deshmukh A
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525779
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes in Patients With Delayed Hospitalization for Non-ST-Segment Elevation Myocardial Infarction.
Cha JJ; Bae S; Park DW; Park JH; Hong SJ; Park SM; Yu CW; Rha SW; Lim DS; Suh SY; Han SH; Woo SI; Lee NH; Choi D; Chae IH; Kim HS; Hong YJ; Ahn Y; Jeong MH; Ahn TH
J Am Coll Cardiol; 2022 Feb; 79(4):311-323. PubMed ID: 35086652
[TBL] [Abstract][Full Text] [Related]
10. Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Aug; 100(32):e26947. PubMed ID: 34397947
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
[TBL] [Abstract][Full Text] [Related]
12. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
Wang HT; Chen YL; Wu CJ
Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
[TBL] [Abstract][Full Text] [Related]
13. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
[TBL] [Abstract][Full Text] [Related]
14. Comparison of zotarolimus- and everolimus-eluting stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention.
Ahmed K; Jeong MH; Chakraborty R; Ahmed S; Hong YJ; Sim DS; Park KH; Kim JH; Ahn Y; Kang JC; Cho MC; Kim CJ; Kim YJ;
J Cardiol; 2014 Oct; 64(4):273-8. PubMed ID: 24631465
[TBL] [Abstract][Full Text] [Related]
15. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic kidney disease on long-term clinical outcomes of everolimus-eluting stent implantation: A subanalysis of the Tokyo-MD PCI registry.
Miyazaki T; Ashikaga T; Asano M; Sasaoka T; Kurihara K; Yoshikawa S; Isobe M;
Catheter Cardiovasc Interv; 2019 Jul; 94(1):E9-E16. PubMed ID: 30714680
[TBL] [Abstract][Full Text] [Related]
18. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
19. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
[TBL] [Abstract][Full Text] [Related]
20. Gender differences and bleeding complications after PCI on first and second generation DES.
Wanha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Morawiec B; Kret M; Pawlowski T; Smolka G; Ochala A; Wojakowski W
Scand Cardiovasc J; 2017 Feb; 51(1):53-60. PubMed ID: 27471987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
